Services / ELAVAY Research

ELAVAY Research

The syndicated platform for Advocacy Intelligence. ELAVAY measures how patient communities perceive your organization, showing where you lead, where gaps remain, and where to act. Benchmarking back to 2015 across 20+ disease states.

Reporting products

Six ways to see clearly

From cross-industry benchmarks to disease-specific deep dives, & fully custom studies built to answer your questions.

01 · Benchmark

Benchmark Report

Your standing versus the industry on advocacy engagement, trust, and impact.

02 · Disease State

Disease-State Reports

Granular insight within a specific condition and its community.

03 · Equity

Health Equity & SDOH

Where social drivers shape access, trust, and outcomes for patients.

04 · Research

Echos in Research

How the patient voice is represented across the research enterprise.

05 · Policy

Policy Pulse

Where policy pressure is moving and what advocates expect next.

06 · Bio

BioAdvocate Benchmark

Advocacy team scope, resourcing, and influence across biopharma.

Ask about Custom ELAVAY & Advoscape
Methodology

Signal you can trust

A disciplined process protects data integrity, so findings hold up in front of leadership.

01

Prioritize

Define the topics and communities that matter most this cycle.

02

Survey

Invite-only fielding to verified advocacy organizations and leaders.

03

Interview

Qualitative depth that explains the "why" behind the numbers.

04

Validate

Data-integrity checks and weighting before anything ships.

Who it's for

Built for life-science teams

Pharma & BiotechMedical DeviceGenomics LabsPayers & PBMsSpecialty Pharmacy
Archō + ELAVAY

Research that activates

ELAVAY is the research engine; Archō turns its findings into internal influence through advisory and training. The data tells you where to act. We help you act on it.

See Advisory & Activation
Proof in the numbers

Real ELAVAY findings, from non-medical switching impact to copay-education gaps and literacy barriers, make the case better than any pitch. Explore a sample.

View sample intelligence
In their words

What advocacy leaders say about ELAVAY

The ELAVAY Survey was the foundation of our continued defense as the industry's number one patient advocacy function for over ten years.
John Hoffman Formerly Leader, Patient Advocacy and Government Affairs, Johnson & Johnson Innovative Medicine
The feedback from the survey is quite insightful. We all work hard, but until you know the community's perception, you really don't know if you are effective. The survey provides feedback, and the granular comments offer better insights about their challenges.
Bruce Taylor Formerly Leader, Patient Advocacy, Dexcom

See where you stand

Request an ELAVAY briefing and we’ll show you what the patient community already knows about your organization.